Arpita Dutt | TalkMarkets | Page 1

Arpita Dutt

Analyst at Zacks Research Pvt. Ltd.
Contributor's Links: Zacks Investment Research
Arpita has been an equity analyst at Zacks Investment Research since March, 2004.
Following: 12 Followers: 1915

All Contributions

Latest Posts
1 to 16 of 92 Posts
1 2 3 ... 6 >>>
3 Pharma And Biotech Stocks To Watch Out For In 2018
Monday, January 15, 2018 10:33 AM EDT
2017 turned out to be a pretty good year for pharma and biotech stocks with the Nasdaq Biotechnology index and the NYSE Arca Pharmaceutical index gaining 18.7% and 11.8%, respectively.
In this article: EIGR, XOMA, ALKS Also: NVS, BIIB
Read
5 Of The Best-Performing Biotech Stocks Of 2017
Sunday, December 31, 2017 3:46 PM EDT
2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to the drug pricing controversy, mixed results, slower-than-expected new product launches, increasing competition and pipeline setbacks.
In this article: XOMA, DVAX, SGMO, ALNY, BLUE, PFE, GILD
Read
Pharma Stock Roundup: Roche, MNK Announce Acquisition Agreements, Regulatory Updates From Novartis
Saturday, December 30, 2017 7:49 PM EDT
Key announcements in the pharma space this week include a couple of acquisition announcements and regulatory updates from Novartis.
In this article: AGN, AZN, BMY, GSK, NVS, RHHBY, MNK
Read
3 Pharma & Biotech Pipeline Areas To Keep An Eye On In 2018
Wednesday, December 20, 2017 12:02 PM EDT
Although there are still a few days left for the year to end, 2017 has turned out to be pretty good for the pharma and biotech sector where FDA approvals are concerned.
In this article: NVS, GILD, JUNO, BLUE, LLY, BIIB, GWPH
Read
4 Retail Stocks To Buy On Strong Industry Sales For November
Monday, December 18, 2017 3:06 PM EDT
The retail sector got a boost with the Commerce Department issuing a report last week on retail and food services sales for the month of November. With expectations high for a strong holiday season, here is a look at four retail stocks.
In this article: DLTR, WMT, ROST, BURL
Read
Pharma Stock Roundup: Teva Announces Major Job Cuts, Lilly Provides 2018 Outlook
Friday, December 15, 2017 11:07 AM EDT
Key announcements this week were Teva Pharmaceutical Industries Ltd.’s restructuring plan and Eli Lilly and Company’s 2018 outlook.
In this article: TEVA, LLY, RHHBY, BMY, MRK, SNY, GSK
Read
3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise
Monday, December 11, 2017 7:45 PM EDT
At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As). However, that did not happen.
In this article: JUNO, BLUE, INCY Also: SNY, AMGN, JNJ, GILD
Read
Pfizer/Merck KGaA Drug Fails In Study, Teva CEO Announces Changes
Friday, December 1, 2017 8:57 AM EDT
While reports about tech giant Amazon meeting generic drugmakers made the rounds, companies like Pfizer and Teva Pharmaceutical Industries Ltd.’s were in the news with the former reporting late-stage data.
In this article: JNJ, PFE, MYL Also: BMY, GSK, TEVA, NVO
Read
FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data
Friday, November 24, 2017 1:53 PM EDT
Pipeline and regulatory updates were the focus this week with the FDA approving the first two-drug HIV treatment in the United States and the European Commission granting approval to Johnson & Johnson’s Tremfya.
In this article: AZN, BMY, MRK, RHHBY, PFE, GSK, JNJ, NVS
Read
5 Leisure & Travel Stocks To Benefit From Thanksgiving Vacation Plans
Thursday, November 23, 2017 1:14 PM EDT
The travel and leisure industry is set to benefit thanks to several factors like a strong economy, higher incomes, higher consumer confidence and a strong labor market.
In this article: SKYW, HTZZ, RCL, MAR, HLT
Read
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod
Friday, November 10, 2017 3:13 PM EDT
Earnings remained in focus this week with companies like AstraZeneca reporting third-quarter results. Meanwhile, companies like Roche and Merck & Co., Inc. were in the news due to regulatory updates.
In this article: AZN, GSK, MRK Also: JNJ, LLY, SNY, RHHBY
Read
Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication For Kymriah
Monday, November 6, 2017 3:22 PM EDT
Major pharma companies like Pfizer, Teva Pharmaceutical Industries Limited, Sanofi, Allergan and Novo Nordisk reported third-quarter results last week.
In this article: PFE, TEVA Also: AZN, BMY, MRK, NVS, VRX
Read
Four Housing Stocks To Buy As New Home Sales Rebound
Monday, October 30, 2017 11:30 AM EDT
The biggest challenge for the housing market is low supply. Factors like rising lumber and land costs as well as tight labor supply and a shortage of land have been hitting inventory build-up.
In this article: BZH, KBH, NVR, TOL
Read
5 Pharma & Biotech Stocks That Could Be Big Winners In Q3 Earnings
Tuesday, October 10, 2017 4:34 PM EDT
Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses. So far this year, the Nasdaq Biotechnology Index is up 25.6%.
In this article: LLY, MRK, PFE, BIIB, VRTX Also: NVS, GILD
Read
Forget Teva, Buy These 5 Drug Stocks Instead
Monday, October 9, 2017 1:43 PM EDT
While Teva deals with these challenges, I have selected five drug companies that look well-positioned.
In this article: PFE, LGND, AMGN, CELG, VRTX Also: MYL, TEVA
Read
Pharma Stock Roundup: Mylan Up, Teva Down On Copaxone News, Lawmakers Question Allergan Deal
Friday, October 6, 2017 10:31 AM EDT
While Mylan and Teva were in the news related to the FDA approval of Mylan’s generic versions of Teva’s top-selling branded drug, Copaxone, Allergan is under fire for its agreement with the Saint Regis Mohawk Tribe for Restasis.
In this article: AGN, TEVA, MYL Also: NVO, SNY, LLY, GSK
Read
1 to 16 of 92 Posts
1 2 3 ... 6 >>>